Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Bioinformatics Platform Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The bioinformatics platform market has experienced robust expansion in recent years. Projections indicate its size will increase from $10.44 billion in 2025 to $11.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. Historically, this growth can be ascribed to several factors, including the proliferation of genomic sequencing projects, the broadening of life science research, the emergence of early bioinformatics tools, collaborative efforts in academic research, and the escalating complexity of biological data.
The bioinformatics platform market size is projected to experience substantial growth in the coming years. This market is anticipated to reach a valuation of $15.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this expansion during the forecast period include the increasing adoption of precision medicine, the integration of artificial intelligence in bioinformatics, the expansion of pharmaceutical research and development, wider embrace of cloud computing in research, and a rising need for accelerated drug discovery. Noteworthy trends expected over the forecast period encompass cloud-based bioinformatics platforms, AI-driven genomic analysis, integrated multi-omics data platforms, collaborative research data ecosystems, and automated bioinformatics workflows.
Download A Free Sample Report For Comprehensive Market Insights:
Bioinformatics Platform Market Expansion Supported By Key Demand Factors
The expanding integration of personalized medicine is projected to stimulate the growth of the bioinformatics platform market in the coming years. Personalized medicine represents a healthcare methodology that tailors treatment and prevention strategies based on an individual’s unique genetic makeup, lifestyle choices, and environmental factors. The escalating need for personalized medicine stems from advancements in genomic technologies, which enable the precise identification of genetic variations associated with diseases, facilitating more targeted and effective therapies. This increasing demand for personalized medicine drives the requirement for sophisticated bioinformatics platforms, as they are vital for analyzing and interpreting extensive genomic and clinical data to formulate individualized treatment plans. For instance, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, marking a substantial increase from the six approvals granted in 2022. Hence, the broader adoption of personalized medicines will propel the expansion of the bioinformatics platform market.
Bioinformatics Platform Market Segment Analysis And Revenue Opportunities
The bioinformatics platform market covered in this report is segmented –
1) By Platform Type: Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural And Functional Analysis Platforms, Other Platforms
2) By Application: Genomics, Proteomics, Drug Discovery, Personalized Medicine, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Other End Users
Subsegments:
1) By Sequence Analysis Platforms: Whole Genome Sequencing (WGS) Platforms, Targeted Sequencing Platforms, RNA Sequencing Platforms, Metagenomic Sequencing Platforms, Exome Sequencing Platforms
2) By Sequence Alignment Platforms: Global Alignment Tools, Local Alignment Tools, Pairwise Alignment Tools, Multiple Sequence Alignment Tools, Structural Alignment Tools
3) By Sequence Manipulation Platforms: Sequence Assembly Tools, Sequence Editing Tools, Sequence Visualization Tools, Sequence Conversion Tools
4) By Structural And Functional Analysis Platforms: Protein Structure Prediction Tools, Structural Bioinformatics Tools, Functional Annotation Tools, Molecular Docking Platforms, Pathway Analysis Tools
5) By Other Platforms: Data Integration Platforms, Data Visualization Platforms, Bioinformatics Workflow Management Platforms, Cloud-Based Bioinformatics Platforms
Bioinformatics Platform Market Trends Reshaping Industry Growth
Major companies in the bioinformatics platform market are creating advanced solutions, like multiomic data mapping platforms, to deliver precise insights and a deeper comprehension of intricate diseases and conditions. These multiomic data mapping platforms are integrated systems designed to analyze and correlate data from various biological levels, including genomics, transcriptomics, proteomics, and metabolomics, ultimately providing a thorough understanding of complex biological processes. For example, in February 2023, BioSkryb Genomics, a US biotechnology company, unveiled its BaseJumper Bioinformatics Platform. This platform is specifically designed to augment the ResolveOME system by simplifying large-scale single-cell informatics. It allows for the swift organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, thus streamlining data interpretation. The platform also features dynamic filtering and an array of visualization tools, enabling researchers from different fields to effortlessly analyze and visualize complex datasets.
Bioinformatics Platform Market Leading Players Shaping Industry Direction
Major companies operating in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Dassault Systèmes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Partek Incorporated, Qiagen N.V.,Genedata AG,DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., Golden Helix Inc., Benchling Inc., Velsera Inc., Seqera Labs, Lifebit Biotech Ltd., Genestack Ltd., Biomatters Ltd., Schrödinger Inc., Chemical Computing Group Inc.
Access The Complete Bioinformatics Platform Market Report:
Bioinformatics Platform Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the bioinformatics platform market in 2025. The regions covered in the bioinformatics platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.